Novo's pill for kids; Altimmune’s $225M offering; Merck teams with Google Cloud

Novo Nordisk’s GLP-1 pill works in kids with diabetes: Type 2 diabetes patients aged 10 to 17 who took Rybelsus for about six months had a statistically significant 0.83% cut in their blood sugar levels ...